Therapy of status epilepticus in adults and children

Current Opinion in Neurology

Volumn 14, Issue 2, 2001, Pages 203-210

  Treiman, David M ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPAM; FELBAMATE; LORAZEPAM; PHENOBARBITAL; PHENYTOIN;

ADULT; CHILD; DRUG EFFICACY; EPILEPTIC STATE; EPILEPTOGENESIS; GRAND MAL SEIZURE; HUMAN; NEUROPROTECTION; REVIEW;

ADULT; ANIMALS; ANTICONVULSANTS; BRAIN; CHILD; CLINICAL TRIALS; DISEASE MODELS, ANIMAL; HUMANS; STATUS EPILEPTICUS;

EID: 0035066972     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200104000-00012     Document Type: Review

References (84)

1. A comparison of four treatments for generalized convulsive status epilepticus
2. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia
3. Incidence of status epilepticus in Rochester, Minnesota, 1965-1984
4. Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR)
5. The association between seizure clustering and convulsive status epilepticus in patients with intractable complex partial seizures
6. Treatment of status epilepticus in a developing country
7. Prevalence of nonconvulsive status epilepticus in comatose patients
8. A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus
9. Electroclinical features of status epilepticus
10. Clinical significance of periodic lateralized epileptiform discharges: Relationship with status epilepticus
11. Increased incidence and impact of nonconvulsive and convulsive seizures after traumatic brain injury as detected by continuous electroencephalographic monitoring
12. Short-term mortality after a first episode of status epilepticus
13. Changes in diffusion-weighted MRI after status epilepticus
14. Periictar diffusion-weighted imaging in a case of lesional epilepsy
15. Reversible changes in echo planar perfusion- and diffusion-weighted MRI in status epilepticus
16. Profound neocortical atrophy after prolonged, continuous status epilepticus
17. Status epilepticus-induced neuronal loss in humans without systemic complications or epilepsy
18. Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels
19. Widespread patterns of neuronal damage following systemic or intracerebral injections of kainic acid: A histological study
20. The role of epileptic activity in hippocampal and 'remote' cerebral lesions induced by kainic acid
21. Kainic acid induced seizures: Neurochemical and histopathological changes
22. Kainic acid induced limbic seizures: Metabolic, behavioral, electroencephalographic and neuropathological correlates
23. The functional anatomy and pathology of lithium-pilocapine and high-dose piloarpine seizures
24. Limbic seizures produced by pilocarpine in rats: Behavioural, electroencephalographic and neuropathological study
25. Systemic cholinergic agents induce seizures and brain damage in lithium-treated rats
26. MRI volumetry of the hippocampus, amygdala, entorhinal cortex, and perirhinal cortex after status epilepticus
27. Magnetic resonance imaging follow-up of progressive hippocampal changes in a mouse model of mesial temporal lobe epilepsy
28. Status epilepticus in the childhood. A review of seven years
29. Does status epilepticus in children cause developmental deterioration and exacerbation of epilepsy?
30. Upregulation of metabotropic glutamate receptor subtype mGluR3 and mGluR5 in reactive astrocytes in a rat model of mesial temporal lobe epilepsy
31. Association between the density of mossy fiber sprouting and seizure frequency in experimental and human temporal lobe epilepsy
32. A new model of chronic temporal lobe epilepsy induced by electrical stimulation of the amygdala in rat
33. Effects of circadian regulation and restactivity state on spontaneous seizures in a rat model of limbic epilepsy
34. Epileptogenesis after status epilepticus reflects age- and model-dependent plasticity
35. Progressive metabolic changes underlying the chronic reorganization of brain circuits during the silent phase of the lithium-pilocarpine model of epilepsy in the immature and adult rat
36. Prevalence of epileptic seizures along the wakefulness sleep cycle in adult rats submitted to status epilepticus in early life
37. Multiple pilocarpine-induced status epilepticus in developing rats: A long-term behavioral and electrophysiological study
38. Epileptogenesis in immature rats following recurrent status epilepticus
39. Does status epilepticus influence the motor development of immature rats?
40. Perforant path stimulation in rats produces seizures, loss of hippocampal neurons, and a deficit in spatial mapping which are reduced by prior MK-801
41. Development of a model of status epilepticus in pigtailed macaque infant monkeys
42. Morphological plasticity in an infant monkey model of temporal lobe epilepsy
43. Prolonged febrile seizures in the immature rat model enhance hippocampal excitability long term
44. Effects of neonatal seizures on subsequent seizure-induced brain injury
45. 2+) ATPase activity in rats
46. Status epilepticus decreases glutamate receptor 2 mRNA and protein expression in hippocampal pyramidal cells before neuronal death
47. Intracerebral injection of caspase-3 inhibitor prevents neuronal apoptosis after kainic acid-evoked status epilepticus
48. Chronic DeltaFosB expression and increased AP-1 transcription factor binding are associated with the long term prasticity changes in epilepsy
49. Serine proteases and brain damage-is there a link?
50. Granule cell neurogenesis after status epilepticus in the immature rat brain
51. Cell damage and neurogenesis in the dentate granule cell layer of adult rats after pilocarpine- or kainate-induced status epilepticus
52. Assessment of inhibition and epileptiform activity in the septal dentate gyrus of freely behaving rats during the first week after kainate treatment
53. Novel role for the NMDA receptor redox modulatory site in the pathophysiology of seizures
54. Self-sustaining status epilepticus: A condition maintained by potentiation of glutamate receptors and by plastic changes in substance P and other peptide neuromodulators
55. Resistance to excitotoxin-induced seizures and neuronal death in mice lacking the preprotachykinin A gene
56. Galanin modulation of seizures and seizure modulation of hippocampal galanin in animal models of status epilepticus
57. Modulation of hippocampal excitability and seizures by galanin
58. In vitro status epilepticus causes sustained elevation of intracellular calcium levels in hippocampal neurons
59. Pilocarpine-induced status epilepticus causes N-methyl-D-aspartate receptor-dependent inhibition of microsomal Mg(2+)/Ca(2+) ATPase-mediated Ca(2+) uptake
60. Transient induction of neuronal nitric oxide synthase in neurons of rat cerebral cortex after status epilepticus
61. Nitric oxide synthase immunoreactivity in the rat hippocampus after status epilepticus induced by perforant pathway stimulation
62. Status epilepticus results in an N-methyl-D-aspartate receptor-dependent inhibition of Ca2+/calmodulin-dependent kinase II activity in the rat
63. Zinc inhibition of gamma-aminobutyric acid(A) receptor function is decreased in the cerebral cortex during pilocarpine-induced status epilepticus
64. Hippocampal neurons express GABA A receptor insensitive to diazepam in hyperexcitable conditions
65. Felbamate in experimental model of status epilepticus
66. Antiepileptic effect of nefiracetam on kainic acid-induced limbic seizure in rats
67. Effects of L-arginine on prevention and treatment of lithiumpilocarpine-induced status epilepticus
68. The anticonvulsant effects of volatile anesthetics on penicillin-induced status epilepticus in cats
69. Neuroprotective effects of estrogens on hippocampal cells in adult female rats after status epilepticus
70. Neuroprotective effects of chronic estradiol benzoate treatment on hippocampal cell loss induced by status epilepticus in the female rat
71. The aspirin metabolite sodium salicylate causes focal cerebral hemorrhage and cell death in rats with kainic acid-induced seizures
72. A self-complementary, self-assembling microsphere system: Application for intravenous delivery of the antiepileptic and neuroprotectant compound felbamate
73. Comparison of plasma benzodiazepine concentrations following intranasal and intravenous administration of diazepam to dogs
74. Rapid-onset intranasal delivery of anticonvulsants: Pharmacokinetic and pharmacodynamic evaluation in rabbits
75. Comparative non-randomized study with midazolam versus thiopental in children with refractory status epilepticus [Portuguese]
76. Midazolam as a first-line agent for status epilepticus in children
77. Prolongation of midazolam half-life after sustained infusion for status epilepticus
78. Phenytoin administration in the newborn and infant
79. Intravenous valproate in pediatric epilepsy patients with refractory status epilepticus
80. Intravenous valproic acid for myoclonic status epilepticus
81. Intravenous valproate is well tolerated in unstable patients with status epilepticus
82. Intravenous valproate associated with significant hypotension in the treatment of status epilepticus
83. Treatment of refractory complex partial status epilepticus with propofol: Case report
84. Evaluation of an algorithm for treatment of status epilepticus in adult patients undergoing video/EEG monitoring